FDA Approvals

Date Posted
Article Title
7/20/2012
Afinitor Approved for Advanced Breast Cancer

Among certain postmenopausal women

7/20/2012
Kyprolis Approved for Multiple Myeloma

In people who have had other therapies

7/18/2012
Another New Weight-Loss Drug Approved

Qsymia sanctioned for obese or overweight people with chronic condition

7/17/2012
7/17/2012
First Drug Approved to Lower Risk of Acquiring HIV

Truvada sanctioned for uninfected adults at higher risk

7/9/2012
New Test Helps Evaluate Cancer Drug's Merit

Erbitux is designed for people with colon cancer

7/5/2012
Test Approved to Help Treat Common Infection in Transplant Patients

CMV preys on people with weaker immune systems

7/3/2012
First Over-the-Counter HIV Test Approved

Results can be obtained within 40 minutes

6/28/2012
Myrbetriq Approved for Overactive Bladder

Some 33 million Americans have the condition

6/27/2012
FDA Clears First Weight-Loss Pill in 13 Years

Belviq designed to make people feel full sooner

6/25/2012
Glaucoma Stent Approved

Along with cataract surgery, helps reduce pressure inside eye

6/15/2012
6/11/2012
Perjeta Approved for Advanced Breast Cancer

But 'production issues' could affect drug's supply

5/17/2012
5/1/2012
Elelyso Approved for Gaucher Disease

People with rare disorder lack enzyme

4/27/2012
Levaquin Approved to Treat or Prevent Plague

Deadly disease rare in the United States

4/27/2012
Votrient Approved to Treat Cancer That Begins in Soft Tissue

Drug inhibits process that fuels tumor growth

4/27/2012
Afinitor Approval Expanded to Include Benign Kidney Tumors

Growths caused by rare genetic disease

4/13/2012
Drug Approved to Treat High Blood Pressure

Dutoprol combines antihypertensive and diuretic

3/27/2012
Omontys Approved for Anemic People With Kidney Disease

Drug designed to stimulate production of red blood cells